Form 4: Surmodics Director Jose H. Bedoya Reports Stock Transactions
SEC Form 4 Filing
Director Jose H. Bedoya reports the acquisition and disposal of Surmodics Inc. common stock on February 14, 2025.
Summary
- On February 14, 2025, Jose H. Bedoya, a director of Surmodics Inc., engaged in transactions involving the company's common stock.
- Bedoya acquired 5,275 shares of common stock at a price of $27.3 per share through the exercise of stock options.
- Concurrently, Bedoya disposed of 4,224 shares at a price of $34.1 per share to cover tax obligations.
- Following these transactions, Bedoya beneficially owns 30,008 shares of Surmodics Inc. common stock.
- This includes 15,772 restricted stock units (RSUs) and 8,430 deferred stock units (DSUs).
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company directors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in beneficial ownership, but the overall effect is likely negligible.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Date of stock option exercise and stock disposal. |
| 02/18/2025 | Date of signature for the Form 4 filing. |
| 02/20/2025 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.